Stock Screener App

Gratuito -

Installare

Diagnostics & Research

0.2784

1.36% 0.0034

Biodesix Inc (BDSX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Biodesix Inc Borsa (BDSX) Ultime notizie

Biodesix, Inc. (NASDAQ:BDSX) Short Interest Up 127.0% in May - Defense World

Biodesix, Inc. (NASDAQ:BDSX) Stock Rockets 30% But Many Are Still Ignoring The Company - simplywall.st

Millennium Management LLC Buys 33,329 Shares of Biodesix, Inc. (NASDAQ:BDSX) - Defense World

Biodesix (BDSX) Partners with APAPP to Enhance Lung Cancer Care - GuruFocus

Biodesix, Inc. Partners with Association of Pulmonary Advanced Practice Providers to Deliver Nation's First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs - MarketScreener

Biodesix Partners with Association of Pulmonary Advanced Practic - GuruFocus

Biodesix partners with Association of Pulmonary APPs for lung cancer education - TipRanks

Public market insider buying at Freehold Royalties (FRU) - The Globe and Mail

Biodesix Partners with Association of Pulmonary Advanced - GlobeNewswire

Biodesix Partners with APAPP to Enhance Lung Cancer Education and Access to Diagnostic Tools - Nasdaq

Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs - Yahoo

Jane Street Group LLC Acquires New Holdings in Biodesix, Inc. (NASDAQ:BDSX) - Defense World

Wall Street’s big rally stalls following some discouraging economic data - The Globe and Mail

Biodesix at 45th Annual William Blair Growth Stock Conference: Lung Health Focus - Investing.com Canada

Northern Trust Corp Grows Stake in Biodesix, Inc. (NASDAQ:BDSX) - Defense World

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting - The Manila Times

Scotiabank Has Lowered Expectations for Biodesix (NASDAQ:BDSX) Stock Price - Defense World

Biodesix Announces New Data on the VeriStrat® Test to be Present - GuruFocus

Biodesix to Present New Data on Host Immune Classifier for NSCLC at 2025 ASCO Annual Meeting - Nasdaq

Game-Changing Cancer Test Triples Survival Rate: New Clinical Data Transforms Lung Cancer Treatment - Stock Titan

Independent Director of Biodesix Picks Up 15% More Stock - Yahoo Finance

Biodesix (BDSX) Target Price Reduced to $2 by Scotiabank | BDSX Stock News - GuruFocus

Biodesix Jumps 46% As Insider Buying, Retail Optimism Offset Scotiabank Target Cut By Stocktwits - Investing.com India

Biodesix Jumps 46% As Insider Buying, Retail Optimism Offset Scotiabank Target Cut - MSN

Scotiabank cuts Biodesix stock target to $2, maintains outlook By Investing.com - Investing.com Canada

Biodesix Approves Reverse Stock Split at Annual Meeting - TipRanks

Scotiabank cuts Biodesix stock target to $2, maintains outlook - Investing.com

Biodesix (BDSX) Sees Target Price Lowered by Scotiabank | BDSX S - GuruFocus

Biodesix (BDSX) Sees Target Price Lowered by Scotiabank | BDSX Stock News - GuruFocus

Biodesix price target lowered to $2 from $3 at Scotiabank - TipRanks

Biodesix to Participate in Upcoming Investor Conferences | BDSX Stock News - GuruFocus

Biodesix to Participate in Upcoming Investor Conferences - GlobeNewswire

Biodesix Executives Set for Major Investor Conferences: William Blair and Craig-Hallum Presentations Ahead - Stock Titan

What's Behind The Big Stock Moves? BDSX, APLM, RNAZ... - Nasdaq

Director’s Massive Stock Purchase Signals Confidence in Biodesix! - TipRanks

Biodesix, Inc. (NASDAQ:BDSX) Shares Bought by Cubist Systematic Strategies LLC - Defense World

Biodesix's (BDSX) "Market Perform" Rating Reaffirmed at William Blair - MarketBeat

Craig Hallum Cuts Biodesix (NASDAQ:BDSX) Price Target to $1.50 - Defense World

William Blair Has Bearish Estimate for Biodesix Q2 Earnings - Defense World

Biodesix revises 2025 revenue guidance to $80M–$85M amid sales force reconfiguration and primary care expansion - MSN

Susquehanna International Group LLP Grows Stock Holdings in Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat

Biodesix, Inc. (NASDAQ:BDSX) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Yahoo Finance

Biodesix, Inc. Earnings Call: Growth Amid Challenges - TipRanks

Biodesix, Inc. (NASDAQ:BDSX) Q1 2025 Earnings Call Transcript - MSN

Analysts Just Slashed Their Biodesix, Inc. (NASDAQ:BDSX) EPS Numbers - simplywall.st

Biodesix Announces New Clinical and Economic Data for Its Nodify Lung® Tests At ISPOR and ATS - marketscreener.com

News Flash: 6 Analysts Think Biodesix, Inc. (NASDAQ:BDSX) Earnings Are Under Threat - Yahoo Finance

Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS | BDSX Stock News - GuruFocus

Biodesix, Inc. to Present New Data on Lung Cancer Diagnosis and Testing at ISPOR and ATS 2025 Conferences - Nasdaq

Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS - GlobeNewswire

New Clinical Data: Biodesix Lung Cancer Tests Could Prevent 60% of Unnecessary Invasive Procedures - Stock Titan

Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award - GlobeNewswire

Biodesix Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga

Craig-Hallum Adjusts Price Target for Biodesix (BDSX) | BDSX Sto - GuruFocus

Diagnostic Leader Biodesix Clinches Elite Colorado Workplace Award, Employee Survey Reveals Why - Stock Titan

DGX

$176.37

0.24%

WAT

$351.33

0.21%

LH

$261.38

0.70%

NTRA

$162.28

0.66%

MTD

$1,205.15

2.26%

IQV

$165.59

0.76%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters